Text Size
8 studies found for:    Sangart

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Conditions: Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
Interventions: Drug: MP4OX;   Drug: Ringer's Lactate solution
2 Completed Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients
Conditions: Hypotension;   Hypoxia
Intervention: Drug: MalPEG-Hb in Lactated Ringer's solution (Hemospan)
3 Completed Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty
Conditions: Hypotension;   Ischemia
Interventions: Biological: MalPEG-Hb solution (Hemospan);   Drug: 6% hetastarch solution (Voluven)
4 Completed Safety Study of Hemospan® in Prostatectomy Patients
Conditions: Blood Loss, Surgical;   Prostatectomy;   Surgery
Interventions: Drug: MP4OX;   Drug: Ringer's lactate
5 Completed Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
Conditions: Vascular Disease;   Chronic Critical Lower Limb Ischemia
Interventions: Drug: Hemospan®;   Drug: Voluven®
6 Completed Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
Conditions: Hypotension;   Ischemia
Interventions: Biological: MalPEG-Hb (Hemospan);   Drug: 6% hetastarch solution (Voluven)
7 Completed Safety Study of MP4CO in Adult Sickle Cell Patients
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
8 Completed Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Conditions: Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
Interventions: Drug: MP4OX;   Drug: Saline
To Top

† Indicates status has not been verified in more than two years